Cardinal Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Jason Hollar
- Full Time Employees
- 57,700
- Sector
- Healthcare
- Industry
- Medical - Distribution
- Address
- 7000 Cardinal Place Dublin OH United States of America 43017
- IPO Date
- Aug 4, 1983
- CIK
- 0000721371
- Website
- cardinalhealth.com
- Similar Companies
- Business
- Cardinal Health, Inc. (NYSE: CAH) provides integrated healthcare services and products, distributing pharmaceuticals and medical supplies to hospitals, pharmacies, and healthcare providers worldwide. The company manufactures branded and private-label medical, surgical, and laboratory products, including masks, gloves, gowns, and exam apparel under brands such as Aspen Surgical, Cardinal Health, and Trudell; offers nuclear pharmacy services, patient safety solutions, and pharmacy management software; and operates through three main segments: Pharmaceutical, Medical, and Home Health & Hospice. Its product portfolio encompasses over 20,000 national brand pharmaceuticals, over 2,000 generic drugs, and a broad range of medical-surgical supplies like needles, syringes, IV sets, and wound care items; services include third-party logistics, specialty pharmaceutical distribution, and proprietary navigation technology for at-home care. Cardinal Health serves independent retail pharmacies, chains, hospitals, ambulatory surgery centers, clinical laboratories, and physician offices primarily in the United States, Canada, and Puerto Rico, with headquarters in Dublin, Ohio, where it was founded in 1971. In recent developments, Cardinal Health completed the acquisition of Integrated Pharmacy Solutions in October 2024, expanding its 503A sterile compounding capabilities to support hospital pharmacies nationwide; launched a new Advanced Call Center in July 2024 to enhance customer service for its Medical segment; and announced a strategic distribution agreement with the Novo Nordisk Patient Assistance Program (PAP) in November 2024 to broaden access to essential medications. The company also secured a five-year Pharmaceutical Supply Agreement with the U.S. Department of Veterans Affairs in September 2024 valued at approximately $9.3 billion, reinforcing its position as a key government supplier; introduced the Cordless Navigation System for orthopedic procedures in 2024; and completed the divestiture of its Health Care Compliance business to RLDatix in December 2024. These moves reflect ongoing efforts to optimize operations, grow in high-margin areas like sterile compounding and navigation technology, and strengthen partnerships amid supply chain challenges.
Cardinal Health Inc (CAH) Shares Surge 3.0% -- What GF Score of 85 Tells Investors
Wall Street Analysts Predict a 25.75% Upside in Cardinal (CAH): Here's What You Should Know
Here's Why Cardinal Health (CAH) is a Strong Value Stock
CAH vs. COR: Which Healthcare Distributor Stock Is the Better Buy?
Why Cardinal Health (CAH) is a Top Growth Stock for the Long-Term
Is Cardinal Health (CAH) a Great Value Stock Right Now?
Is Cardinal (CAH) a Buy as Wall Street Analysts Look Optimistic?
Can CAH's Surging Other Growth Businesses Become Its Next Profit Engine?
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
3 Reasons Why Growth Investors Shouldn't Overlook Cardinal (CAH)
April 2026 Dividend Income Report - An Insane 80% Dividend Growth Rate
Is CAH Becoming the Backbone of US Healthcare Infrastructure?
Kiplinger’s May 2026 Letter Says Yields From 3% to 13% Are Available Right Now Despite Iran War Uncertainty
CAH Stock Down Nearly 9.4% YTD: Should You Buy, Hold or Sell?
Cardinal Health Was Supposed to Beat UnitedHealth. Did It? Will It?
Cardinal Health, Inc. (CAH) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Can CAH Sustain Growth on Booming Pharmaceutical & Specialty Segment?
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here's Why Cardinal Health (CAH) is a Strong Value Stock